NVNOenVVeno Medical Corporation
10.29USD-1.81%Mkt Cap: 7.03M $P/E:

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The compa…

Key Statistics

Company
Market Cap7.03M $
Enterprise Value-13.89M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-19.47M $
Revenue/Share
Last Price10.29 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees33
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.67
PEG
EV/EBITDA0.81
EV/Revenue
P/S
P/B0.34
EPS (TTM)-24.76
EPS (Forward)-6.22
52W Range
8.6701% of range178.15
52W High178.15 USD
52W Low8.670 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-71.77%
ROA-65.87%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-15.57M $
CapEx (TTM)5.00K $
FCF Margin
FCF Yield-136.52%
Net Debt-20.98M $
Net Debt/EBITDA1.22
Balance Sheet
Debt/Equity0.03
Current Ratio11.70
Quick Ratio11.39
Book Value/Sh30.71 USD
Cash/Share31.47 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateNov 30, 2020
Splits
Last Split1:35
Split DateJan 20, 2026
Analyst Consensus
Rating
Target (Mean)30.00 USD
Upside (mean)+191.5%
Target Range30.00 USD30.00 USD
# Analysts1
Ownership
Shares Out.682.72K
Float501.26K
Insiders13.08%
Institutions23.32%
Short Interest
Short Ratio0.9d
Short % Float2.70%
Short % Out.2.68%
Shares Short18.29K
Short (prev mo.)10.78K
Technical
SMA 5010.68 (-3.6%)
SMA 20011.62 (-11.4%)
Beta1.05
S&P 52W Chg18.16%
Avg Vol (30d)22.25K
Avg Vol (10d)13.24K
Technical Indicators
RSI (14)47.5
MACD0.0923
MACD Signal0.0492
MACD Hist.+0.0431
BB Upper11.53 USD
BB Middle10.67 USD
BB Lower9.810 USD
BB Width16.13%
ATR (14)0.7565 USD
Vol Ratio (20d)1.32x